AR014000A1 - Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro - Google Patents
Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuroInfo
- Publication number
- AR014000A1 AR014000A1 ARP980105483A ARP980105483A AR014000A1 AR 014000 A1 AR014000 A1 AR 014000A1 AR P980105483 A ARP980105483 A AR P980105483A AR P980105483 A ARP980105483 A AR P980105483A AR 014000 A1 AR014000 A1 AR 014000A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- work
- arylamine
- cyclooxygenase
- inhibitors
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000001605 fetal effect Effects 0.000 title 1
- 238000012423 maintenance Methods 0.000 title 1
- 230000002028 premature Effects 0.000 title 1
- -1 cyano, carboxyl Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 150000003973 alkyl amines Chemical class 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 150000001412 amines Chemical class 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 208000006399 Premature Obstetric Labor Diseases 0.000 abstract 1
- 206010036595 Premature delivery Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 1
- 125000004689 alkyl amino carbonyl alkyl group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 150000004982 aromatic amines Chemical class 0.000 abstract 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 abstract 1
- 125000005164 aryl thioalkyl group Chemical group 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004966 cyanoalkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004367 cycloalkylaryl group Chemical group 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Esta invencion se relaciona con el uso de inhibidores de la ciclooxigenasa -2, o con derivados de los mismos, en la prevencion y el tratamiento deltrabajo de parto prematuro. En particular, la invencion describe un método para prevenir y tratar un parto prematuro en un sujeto, comprendiendo dicho métodoel tratamiento del sujeto con una cantidad terapéuticamente efectiva de un compuesto de formula (I) donde A es un sustituyente en anillo de 5 o 6 miembrosseleccionado entre anillos heterocíclicos y carbocíclicos insaturados o parcialmente insaturados, donde R1 es por lo menos un sustituyenteseleccionado entre heterociclos, cicloalquilo, cicloalquenilo y arilo, donde R1 está sustituido optativamente en una posicion sustituible, con uno o másradicales seleccionados entre alquilo, haloalquilo, ciano, carboxilo, alcoxicarbonilo, hidroxilo, hidroxialquilo, haloalcoxi, amina, alquilamina,arilamina, nitro, alcoxialquilo, alquilsulfinilo, halo, alcoxi y alquiltio, donde R3 se selecciona entre alquilo y amina y R3 es un radical seleccionadoentre halo, alquilo, alquenilo, alquinilo, oxo, ciano, carboxilo, cianoalquilo, heterocicloxi, alquiloxi, alquiltio, alquilcarbonilo, cicloalquilo arilo,haloalquilo, heterociclo, cicloalquenilo, aralquilo, heterocicloalquilo, acilo alquiltioalquilo, hidroxialquilo, alcoxicarbonilo, arilcarbonilo,aralquilcarbonilo,aralquenilo, alcoxialquilo, ariltioalquilo, ariloxialquilo, aralquiltioalquilo, aralcoxialquilo, alcoxiaralcoxialquilo,alcoxicarbonilalquilo, aminocarbonilo, aminocarbonilalquilo, alquilaminocarbonilo, N-arilaminocarbonilo, N-alquil-N-arilaminocarbonilo,alquilaminocarbonilalquilo, carboxialquilo, alquilamina, N-arilamina N-aralquilamina, N-alquil-N-aralquilamina, N-alquil-N-arilamina,
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6388997P | 1997-10-31 | 1997-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014000A1 true AR014000A1 (es) | 2001-01-31 |
Family
ID=22052179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105483A AR014000A1 (es) | 1997-10-31 | 1998-10-30 | Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1027048A2 (es) |
| JP (1) | JP2001521889A (es) |
| AR (1) | AR014000A1 (es) |
| AU (1) | AU758566B2 (es) |
| BR (1) | BR9813164A (es) |
| CA (1) | CA2308639A1 (es) |
| TW (2) | TW200404535A (es) |
| WO (1) | WO1999022720A2 (es) |
| ZA (1) | ZA989876B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001274858A1 (en) * | 2000-06-08 | 2001-12-17 | Board Of Regents, The University Of Texas System | Heterocycle derivatives and methods of use for treating anthrax infection |
| WO2004098619A2 (en) | 2003-05-07 | 2004-11-18 | Osteologix A/S | Treating cartilage / bone conditions with water-soluble strontium salts |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2161789A1 (en) * | 1993-05-13 | 1994-11-24 | Jacques Yves Gauthier | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| WO1997031631A1 (en) * | 1996-02-27 | 1997-09-04 | Rpms Technology Limited | Cox-2 selective inhibitors for managing labour and uterine contractions |
| US5677318A (en) * | 1996-07-11 | 1997-10-14 | Merck Frosst Canada, Inc. | Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents |
-
1998
- 1998-10-27 AU AU11926/99A patent/AU758566B2/en not_active Ceased
- 1998-10-27 JP JP2000518654A patent/JP2001521889A/ja not_active Withdrawn
- 1998-10-27 BR BR9813164-8A patent/BR9813164A/pt not_active Application Discontinuation
- 1998-10-27 CA CA002308639A patent/CA2308639A1/en not_active Abandoned
- 1998-10-27 EP EP98955026A patent/EP1027048A2/en not_active Ceased
- 1998-10-27 WO PCT/US1998/022246 patent/WO1999022720A2/en not_active Ceased
- 1998-10-29 ZA ZA9809876A patent/ZA989876B/xx unknown
- 1998-10-30 AR ARP980105483A patent/AR014000A1/es not_active Application Discontinuation
- 1998-10-30 TW TW092134686A patent/TW200404535A/zh unknown
- 1998-10-30 TW TW087118094A patent/TW577739B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU758566B2 (en) | 2003-03-27 |
| ZA989876B (en) | 1999-10-29 |
| WO1999022720A3 (en) | 1999-08-26 |
| JP2001521889A (ja) | 2001-11-13 |
| TW577739B (en) | 2004-03-01 |
| WO1999022720A2 (en) | 1999-05-14 |
| AU1192699A (en) | 1999-05-24 |
| TW200404535A (en) | 2004-04-01 |
| CA2308639A1 (en) | 1999-05-14 |
| BR9813164A (pt) | 2000-08-22 |
| EP1027048A2 (en) | 2000-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23116A3 (es) | Derivados de bencensulfonamida sustituida, como inhibidores de cox-2 | |
| NZ509755A (en) | Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia | |
| PT772597E (pt) | Pirazoles 3,4-substituidos para o tratamento de inflamacao | |
| PL322419A1 (en) | Novel substituted compounds of biphenyl or phenylopyridine, method of obtaining them as well as pharmaceutic compositions containing such compounds | |
| PH12021500049A1 (en) | 2,3-dihydroquinazolin compounds as nav1.8 inhibitors | |
| BRPI0413848A (pt) | composto, processo para preparar o composto, composição terapêutica para prevenir inflamação e apoptose, método para prevenir inflamação e apoptose, e, uso de composto inibidor de caspase, ou de seu sal, ou de seu estereoisÈmero | |
| UY38186A (es) | Sal sódica de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1-isopropil-1h-pirazol-3-sulfonamida | |
| LV12209A (lv) | Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori | |
| MY126917A (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
| CY1107069T1 (el) | Χρηση των αναστολεων της cox-2 σαν ανοσοδιεγερτες στη θεραπεια του hiv ή του aids | |
| HUP0004350A2 (hu) | Vegyületek női szexuális diszfunkció kezelésére | |
| ES2120728T3 (es) | Inhibidores de la agregacion de plaquetas. | |
| AR014000A1 (es) | Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro | |
| BRPI0417007A (pt) | agentes antivirais de diazaindol-dicarbonil-piperazinila | |
| PT880504E (pt) | Imidazoles substituidos por heterociclo para o tratamento de inflamacao | |
| DK0659193T3 (da) | Blodpladeaggregationsinhibitorer | |
| KR950010894A (ko) | 자궁 섬유증의 억제 방법 | |
| AR038199A1 (es) | Terapia combinada para el tratamiento de infecciones bacterianas | |
| HUP9901505A2 (hu) | Dehidroepiandroszteron és aromatázgátlók kombinációja és e kombináció felhasználása férfiak relatív és abszolút androgénhiányának kezelésére szolgáló gyógyszerkészítmények előállítására | |
| CR20210143A (es) | Utilización de un inhibidor de catepsina s contra la formación de anticuerpos anti-fármaco | |
| AR020306A1 (es) | Composicion terapeutica y su uso como inhibidora de la ciclooxigenasa-2 en la prevencion de alteraciones cardiovasculares. | |
| FR3077201B1 (fr) | Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau | |
| AR035768A1 (es) | Compuesto derivado de bencimidazol y su uso en la fabricacion de un medicamento | |
| AR011251A1 (es) | Metodo de utilizacion de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de neoplasias | |
| DE50211752D1 (de) | Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FB | Suspension of granting procedure |